News and Press Releases

Derstine Joins FTI as Director of Marketing

Monday, June 10, 2002
Download this FTI news release (PDF).

Fluorous Technologies, Inc. (FTI) announced today that Mr. Kyle Derstine has joined the company as Director of Marketing. Mr. Derstine is responsible for managing product and service marketing as well as channel partnerships. Mr. Derstine has experience in market research, strategic planning, and business planning for chemical products. In addition, he gained four years of project management experience in a GMP environment while supporting biotechnology production in Genentech's South San Francisco plant as well as constructing Genentech's Vacaville plant. Prior to that Mr. Derstine spent two years designing and constructing a herbicide plant for FMC Corporation while employed by John Brown Engineering. Mr. Derstine earned a B.S in Chemical Engineering from Lehigh University and a MBA from Carnegie Mellon University.

"I'm excited to market products and services based on a cutting edge chemical technology developed by a strong scientific team. Given our synthesis and separation advantages, I'm confident FTI will make quick inroads into both pharmacteutical and biotechnology firms," said Mr. Derstine.

"Kyle's combination of practice with experience in the life science arena, along with his outstanding academic credentials qualifies him an ideal person to lead our marketing efforts," said Dr. Philip Yeske, Executive Vice President and COO of FTI. "We welcome him onboard and look forward to his contributions."

FTI (www.fluorous.com) is a Pittsburgh-based chemical technology company focused on the life sciences market. For further information please contact us at bizdev@fluorous.com.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risk and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including risks relating to the early stage of products under development; uncertainties related to patent protection; dependence on third parties, including strategic partners, collaborators and key personnel; future capital needs; and risks relating to the development and commercialization, if any, of Fluorous Technologies' proposed products (such as marketing, manufacturing, safety, regulatory, patent or product liability, supply, competition and other risks).